Outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma.

@article{Kikuchi2015OutcomeOR,
  title={Outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma.},
  author={Taku Kikuchi and Takehiko Mori and Yuya Koda and Sumiko Kohashi and Jun Kato and Takaaki Toyama and Tomonori Nakazato and Yoshinobu Aisa and Takayuki Shimizu and Shinichiro Okamoto},
  journal={International journal of hematology},
  year={2015},
  volume={102 6},
  pages={670-7}
}
We retrospectively evaluated single-institute outcomes of allogeneic hematopoietic stem cell transplantation (allo-HSCT) with a reduced-intensity conditioning regimen consisting of fludarabine (125 mg/m²) and melphalan (140 mg/m²) for multiple myeloma. Twenty-three patients (median age: 46 years) were evaluated. Stem cell sources were bone marrow or peripheral blood stem cells from siblings (n = 4) and bone marrow from unrelated donors (n = 19). For graft-versus-host disease prophylaxis… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS
1 Citations
29 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 29 references

Similar Papers

Loading similar papers…